Beclometasoni dipropionas, Formoteroli fumaras dihydricus
Medicinal product name | Foster 200 micrograms/6 micrograms per actuation pressurised inhalation, solution |
||||||
---|---|---|---|---|---|---|---|
Pharmaceutical form | Pressurised inhalation, solution | ||||||
Strength | 200 micrograms/6 micrograms | ||||||
Information from the MAH on shortages | No information on expected shortages | ||||||
Availability of medicinal product |
|
||||||
Legal status | NHS Reimbursed medicines |
Prescription (Pr.)||||||
Package leaflet | 02-11-2023 | ||||||
Summary of product characteristics | 02-11-2023 | ||||||
ATC code | R03AK08 – Drugs for obstructive airway diseases | ||||||
Information for Marketing authorisation holders | View |
Additional information regarding the use for persons aged 75+
If used as "DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES" | ||
---|---|---|
Substance | Class | Comment |
Beclometasoni dipropionas | A | Suitable for older adults. Consider possible systemic adverse effects with high doses. |
Formoteroli fumaras dihydricus | A | Suitable for older adults. Potentiates sympathomimetic effects. May cause hypokalaemia. |
Medicinal products (3)
Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
---|---|---|---|---|---|---|
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N1: 1 × 120 (200 µg/6 µg) |
Inhaler | 15-0197-01 |
Labelling text Dec 9, 2021 |
|
Is available (according to the information provided by wholesalers) (755 containers) |
Tamro, Magnum Medical, Recipe Plus, Euroaptieka, Oribalt Rīga, Medelens+ |
N1: 1 × 180 (200 µg/6 µg) |
Inhaler |
€ 82.01 * |
15-0197-02 |
Labelling text Dec 9, 2021 |
Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N2: 2 × 120 (200 µg/6 µg) |
Inhaler | 15-0197-03 |
Labelling text Dec 9, 2021 |
Registration information
Marketing authorisation No. | 15-0197 |
---|---|
Date of authorisation | Sep 9, 2015 |
Marketing authorisation holder, country | Chiesi Pharmaceuticals GmbH, Austria |